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Reply to Saliou et al
TO THE EDITOR—We thank Saliou et al [1]
for their comments and interest in our re-
view article [2].Fungal outbreaks and infec-
tions can occur in healthcare settings with
or without construction, renovation, or
demolition. Our review uniquely focused
on human fungal outbreaks and infections
in healthcare settings during construction,
renovation, or demolition, avoiding the
combined analysis of infections and con-
tamination [2]. Eckmanns et al reviewed
the efficacy of high-efficiency particulate
air (HEPA) filtration in the prevention of
fungal infection and mortality in patients
who received a bone marrow transplant
[3]. Their study is not relevant because
they assessedHEPA filtration as part of rou-
tine care and not during hospital construc-
tion, renovation, or demolition (only 1 of
the 16 articles they reviewed assessed pro-
tection during hospital construction) [3].
The Centers for Disease Control and
Prevention recommend use of HEPA fil-
tration systems for high-risk patients [4],
and we agree with the authors’ comments
that outbreaks could be decreased, in
part, by the use of HEPA systems. As
described in the authors’ data and in
our review [1, 2], installation of a HEPA
filter system in combination with other
environmental measures reduces fungal
spore counts as measured by air sampling
from the environment of healthcare facili-
ties during construction, renovation, or
demolition, thereby preventing fungal out-
breaks and infections. However, in the ma-
jority of articles that described successful
control using HEPA filtration, standard
preventive measures (eg, relocating high-
risk patients, sealing off the construction
site, avoiding unnecessary traffic) and/or
antifungal prophylaxis were implemented
simultaneously, demonstrating that a bun-
dle approach of prevention and control
measures based on infection control risk
assessment is essential [2]. It remains un-
clear to what extent HEPA filtration alone
contributes to reduction of fungal out-
breaks and infections during construction,
renovation, or demolition.
It is important to note that there is no
scientific evidence to establish a tolerable
limit of fungal spores in air samples for
the prevention of fungal outbreaks and in-
fections during construction, renovation,
or demolition [2]. A major problem in
comparing air sampling for fungi is that
there is no standardized method of air
sampling, which results in difficulty when
comparing studies. Our literature review
demonstrated that there is not a direct re-
lationship between fungal spore concentra-
tion by air sampling and fungal infections
in healthcare settings during construction
and renovation [2]. We agree that HEPA
filtration systems contribute to the reduc-
tion of air contamination. However, given
the lack of direct causation between air-
borne fungal levels and clinical outcomes,
further studies are needed to assess the
benefits of HEPA filtration during hospital
construction, renovation, or demolition.
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